TherapeuticsMD Inc./$TXMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
Ticker
$TXMD
Sector
Primary listing
Employees
1
Headquarters
Website
TXMD Metrics
BasicAdvanced
$24m
131.91
$0.02
-
-
Price and volume
Market cap
$24m
52-week high
$2.95
52-week low
$0.98
Average daily volume
22k
Financial strength
Current ratio
3.108
Quick ratio
2.368
Long term debt to equity
17.885
Total debt to equity
17.885
Profitability
EBITDA (TTM)
-1.407
Gross margin (TTM)
100.00%
Net profit margin (TTM)
5.34%
Operating margin (TTM)
-53.39%
Effective tax rate (TTM)
27.12%
Revenue per employee (TTM)
$3,350,000
Management effectiveness
Return on assets (TTM)
-2.95%
Return on equity (TTM)
0.32%
Valuation
Price to earnings (TTM)
131.911
Price to revenue (TTM)
7.042
Price to book
0.88
Price to tangible book (TTM)
1.01
Price to free cash flow (TTM)
8.83
Free cash flow yield (TTM)
11.32%
Free cash flow per share (TTM)
0.231
Growth
Revenue change (TTM)
82.13%
Earnings per share change (TTM)
-108.29%
3-year revenue growth (CAGR)
-63.63%
10-year revenue growth (CAGR)
-16.60%
3-year earnings per share growth (CAGR)
-90.18%
10-year earnings per share growth (CAGR)
-51.94%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for TherapeuticsMD Inc. stock?
TherapeuticsMD Inc. (TXMD) has a market cap of $24M as of May 20, 2026.
What is the P/E ratio for TherapeuticsMD Inc. stock?
The price to earnings (P/E) ratio for TherapeuticsMD Inc. (TXMD) stock is 131.91 as of May 20, 2026.
Does TherapeuticsMD Inc. stock pay dividends?
No, TherapeuticsMD Inc. (TXMD) stock does not pay dividends to its shareholders as of May 20, 2026.
When is the next TherapeuticsMD Inc. dividend payment date?
TherapeuticsMD Inc. (TXMD) stock does not pay dividends to its shareholders.
What is the beta indicator for TherapeuticsMD Inc.?
TherapeuticsMD Inc. (TXMD) does not currently have a Beta indicator.